Zenotech Laboratories submits monitoring agency report

03 Feb 2020 Evaluate

In accordance with the Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 16(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2004, as amended from time to time, Zenotech Laboratories has informed about submission of Monitoring Agency Report dated January 30, 2020, in respect of utilization of proceeds of Rights Issue for the quarter ended September 30, 2019 issued by Axis Bank, Monitoring Agency. Further, it is informed that there is no deviation/ variation in the utilization of proceeds as mentioned in the objects stated in the Letter of Offer dated June 21, 2017, in respect of its Rights Issue of the Company in accordance with the Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Zenotech Laboratorie Share Price

47.38 0.58 (1.24%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×